These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26862156)

  • 1. MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.
    Wadosky KM; Berthiaume JM; Tang W; Zungu M; Portman MA; Gerdes AM; Willis MS
    J Mol Endocrinol; 2016 Apr; 56(3):273-90. PubMed ID: 26862156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.
    Parry TL; Desai G; Schisler JC; Li L; Quintana MT; Stanley N; Lockyer P; Patterson C; Willis MS
    Cardiovasc Pathol; 2016; 25(2):127-140. PubMed ID: 26764147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
    Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
    Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination.
    Rodríguez JE; Liao JY; He J; Schisler JC; Newgard CB; Drujan D; Glass DJ; Frederick CB; Yoder BC; Lalush DS; Patterson C; Willis MS
    Mol Cell Endocrinol; 2015 Sep; 413():36-48. PubMed ID: 26116825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin ligase MuRF1 protects against cardiac ischemia/reperfusion injury by its proteasome-dependent degradation of phospho-c-Jun.
    Li HH; Du J; Fan YN; Zhang ML; Liu DP; Li L; Lockyer P; Kang EY; Patterson C; Willis MS
    Am J Pathol; 2011 Mar; 178(3):1043-58. PubMed ID: 21356357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling.
    Wadosky KM; Rodríguez JE; Hite RL; Min JN; Walton BL; Willis MS
    Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E723-39. PubMed ID: 24425758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rise above: muscle ring-finger-1 (MURF1) regulation of cardiomyocyte size and energy metabolism.
    Patterson C; Willis MS; Portbury A
    Trans Am Clin Climatol Assoc; 2011; 122():70-81. PubMed ID: 21686210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canonical and Noncanonical Contribution of Thyroid Hormone Receptor Isoforms Alpha and Beta to Cardiac Hypertrophy and Heart Rate in Male Mice.
    Geist D; Hönes GS; Grund SC; Pape J; Siemes D; Spangenberg P; Tolstik E; Dörr S; Spielmann N; Fuchs H; Gailus-Durner V; Hrabe de Angelis M; Mittag J; Engel DR; Führer D; Lorenz K; Moeller LC
    Thyroid; 2024 Jun; 34(6):785-795. PubMed ID: 38757582
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo.
    Willis MS; Wadosky KM; Rodríguez JE; Schisler JC; Lockyer P; Hilliard EG; Glass DJ; Patterson C
    Cell Biochem Funct; 2014 Jan; 32(1):39-50. PubMed ID: 23512667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMP-activated protein kinase regulates E3 ligases in rodent heart.
    Baskin KK; Taegtmeyer H
    Circ Res; 2011 Oct; 109(10):1153-61. PubMed ID: 21921267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I.
    Kedar V; McDonough H; Arya R; Li HH; Rockman HA; Patterson C
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18135-40. PubMed ID: 15601779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy.
    Arya R; Kedar V; Hwang JR; McDonough H; Li HH; Taylor J; Patterson C
    J Cell Biol; 2004 Dec; 167(6):1147-59. PubMed ID: 15596539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis.
    Koyama S; Hata S; Witt CC; Ono Y; Lerche S; Ojima K; Chiba T; Doi N; Kitamura F; Tanaka K; Abe K; Witt SH; Rybin V; Gasch A; Franz T; Labeit S; Sorimachi H
    J Mol Biol; 2008 Mar; 376(5):1224-36. PubMed ID: 18222470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.
    Li HH; Kedar V; Zhang C; McDonough H; Arya R; Wang DZ; Patterson C
    J Clin Invest; 2004 Oct; 114(8):1058-71. PubMed ID: 15489953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle RING-finger protein-1 (MuRF1) functions and cellular localization are regulated by SUMO1 post-translational modification.
    Heras G; Namuduri AV; Traini L; Shevchenko G; Falk A; Bergström Lind S; Jia M; Tian G; Gastaldello S
    J Mol Cell Biol; 2019 May; 11(5):356-370. PubMed ID: 29868881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment.
    Hwee DT; Gomes AV; Bodine SC
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E967-77. PubMed ID: 21828340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo.
    Willis MS; Ike C; Li L; Wang DZ; Glass DJ; Patterson C
    Circ Res; 2007 Mar; 100(4):456-9. PubMed ID: 17272810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripartite motif 32 prevents pathological cardiac hypertrophy.
    Chen L; Huang J; Ji Y; Zhang X; Wang P; Deng K; Jiang X; Ma G; Li H
    Clin Sci (Lond); 2016 May; 130(10):813-28. PubMed ID: 26884348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling?
    Conraads VM; Vrints CJ; Rodrigus IE; Hoymans VY; Van Craenenbroeck EM; Bosmans J; Claeys MJ; Van Herck P; Linke A; Schuler G; Adams V
    Basic Res Cardiol; 2010 Mar; 105(2):219-26. PubMed ID: 19859778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1.
    Willis MS; Parry TL; Brown DI; Mota RI; Huang W; Beak JY; Sola M; Zhou C; Hicks ST; Caughey MC; D'Agostino RB; Jordan J; Hundley WG; Jensen BC
    Circ Heart Fail; 2019 Mar; 12(3):e005234. PubMed ID: 30871347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.